Literature DB >> 34909059

Exploring the interaction of quercetin-3-O-sophoroside with SARS-CoV-2 main proteins by theoretical studies: A probable prelude to control some variants of coronavirus including Delta.

Suliman Khan1,2, Arif Hussain3, Yasaman Vahdani4, Hamideh Kooshki5, Bashdar Mahmud Hussen6, Setareh Haghighat7, Mohammed Fatih Rasul8, Hazha Jamal Hidayat9, Anwarul Hasan10,11, Zehra Edis12,13, Samir Haj Bloukh13,14, Shahab Kasravi15, Mohammad Mahdi Nejadi Babadaei16, Majid Sharifi5, Qian Bai17, Jianbo Liu1, Bowen Hu18, Keivan Akhtari19, Mojtaba Falahati5.   

Abstract

The aim of this study was to investigate the mechanism of interaction between quercetin-3-O-sophoroside and different SARS-CoV-2's proteins which can bring some useful details about the control of different variants of coronavirus including the recent case, Delta. The chemical structure of the quercetin-3-O-sophoroside was first optimized. Docking studies were performed by CoV disease-2019 (COVID-19) Docking Server. Afterwards, the molecular dynamic study was done using High Throughput Molecular Dynamics (HTMD) tool. The results showed a remarkable stability of the quercetin-3-O-sophoroside based on the calculated parameters. Docking outcomes revealed that the highest affinity of quercetin-3-O-sophoroside was related to the RdRp with RNA. Molecular dynamic studies showed that the target E protein tends to be destabilized in the presence of quercetin-3-O-sophoroside. Based on these results, quercetin-3-O-sophoroside can show promising inhibitory effects on the binding site of the different receptors and may be considered as effective inhibitor of the entry and proliferation of the SARS-CoV-2 and its different variants. Finally, it should be noted, although this paper does not directly deal with the exploring the interaction of main proteins of SARS-CoV-2 Delta variant with quercetin-3-O-sophoroside, at the time of writing, no direct theoretical investigation was reported on the interaction of ligands with the main proteins of Delta variant. Therefore, the present data may provide useful information for designing some theoretical studies in the future for studying the control of SARS-CoV-2 variants due to possible structural similarity between proteins of different variants.
© 2021 The Author(s).

Entities:  

Keywords:  COVID-19; Molecular docking; Molecular dynamic; Quercetin-3-O-sophoroside; SARS-CoV-2; Variants

Year:  2021        PMID: 34909059      PMCID: PMC8317451          DOI: 10.1016/j.arabjc.2021.103353

Source DB:  PubMed          Journal:  Arab J Chem        ISSN: 1878-5352            Impact factor:   5.165


Introduction

Given the unique characteristics of the genetic material of coronaviruses (CoV), as well as the mechanism of their proliferation, the emergence of the severe acute respiratory syndrome CoV 2 (SARS-CoV-2) has not been unexpected for virologists (Evangelin et al., 2020). Among these special features, the high genetic recombination rate of this virus has been led to the emergence of new and unknown strains (Deng et al., 2020). The reason for this high recombinant frequency can be attributed to the very long genetic material of the virus compared to other viruses, the complex proliferation, and ultimately to the wide host range of these viruses in humans and animals (Evangelin et al., 2020, Deng et al., 2020, Wu et al., 2020). In order to treat this virus, in addition to sufficient knowledge of this invasive and contagious virus (Zuo et al., 2020, Ashour et al., 2020), it is necessary for different countries to make correct and timely control decisions to take personal protective and hygienic measures (Ong et al., 2020, Ferretti et al., 2020). Due to severe tissue damage caused by SARS-CoV and middle east respiratory syndrome (MERS-CoV) infection, the mortality rate in infected patients requiring mechanical ventilation (artificial respiration) has been very serious (Yang et al., 2020, Zhou et al., 2020). To date, there is no specific antiviral drug for the treatment of CoV (Zhou et al., 2020, Wu et al., 2020), and the main solutions are based on supportive care, such as maintaining vital signs, regulating oxygen and blood pressure, and reducing side effects such as secondary infections or organ failure (Gheblawi et al., 2020, Abassi et al., 2020, Yan et al., 2020). Based on the previous studies, a combination of protease inhibitors, lopinavir and ritonavir drugs has been shown to significantly improve the condition of COVID-19 patients (Muralidharan et al., 2021, Stower, 2020, Moro et al., 2020). The results of in vitro and in vivo studies show that a combination of lopinavir, ritonavir, and interferon β may be effective against MERS infection (Sheahan et al., 2020). Recent studies have shown that viral proteins may be potential models for the design of new antiviral drugs to prevent the proliferation of SARS-CoV-2 and possible different variants (Zhang et al., 2020, Hu et al., 2003, Nabavi et al., 2020). The computational methods are widely used in the discovery, design, and optimization of potential compounds based on their structure, in which small molecules are docked into the structure of the target macromolecules and rated for their binding at the target site (Choudhary et al., 2020, Cavasotto and Filippo, 2020). The study of SARS-CoV-2 inhibitors to develop an effective drug to reduce mortality in COVID-19 patients has been a new topic in recent years (Choudhary et al., 2020, Cavasotto and Filippo, 2020, Zhang et al., 2020, Chowdhury et al., 2020). At present, the lack of appropriate methods to identify inhibitors' mechanism of action on SARS-CoV-2 function and maybe different variants, including Delta and the relationship between their chemical structure and antiviral effect encourages us to further examine their inhibitory effects against COVID-19 (Farinholt et al., 2021, Enmozhi et al., 2021). Software and computational methods of drug design have been a new approach that their emergence and generality have been accompanied by advances in computing power over decades (Farinholt et al., 2021, Enmozhi et al., 2021). These methods are used in conjunction with biological experiments to establish a relationship between the structure and activity of pharmaceutical compounds, the discovery of new compounds, the prediction of the biological activities of designed compounds, and the understanding of biochemical reactions and relative processes (Sonawane et al., 2020, Bobrowskia et al., 2020). In addition, these methods can be used to predict how the designed compounds bind to the target protein, evaluate the energy difference between different compound conformers, and explain the mechanisms of reaction, effect of different groups, decompositions in the chemical structure of compounds, and their performance (Farinholt et al., 2021, Enmozhi et al., 2021, Sonawane et al., 2020, Bobrowskia et al., 2020). Quercetin-3-O-sophoroside as a major member of quercetin glucoside group is a well-acknowledged anti- inflammatory, anti-oxidant and anti-cancer edible compound (30]. Broccoli, and Poacynum hendersonii leaves have a high content of quercetin glucosides (Jeffery and Araya, 2009, An et al., 2013). Lee et al. [a] studied the inhibitory activity of quercetin-3-O-sophoroside against H1N1, H3N2, and H5N1 viruses. They suggested that the size of sugar moiety on quercetin-3-sophoroside and other flavonoids can affect the antiviral effect of these compounds. Hollman et al. (1999) studied the catabolism of quercetin-3-O-sophoroside in the small intestine. Also, it is reported that during this process the sugar moiety is removed (Wang et al., 2020). Since in this study the molecule has been studied in its intact form, non-oral methods should be prescribed in its possible medical use for the treatment of viral disease. Accessibility of the target protein and lack of closely related host cell counterparts which improve the inhibitory potency and fewer off-target effects against host proteins, are two important aspects in selecting favorable receptors among a wide variety of target proteins. Therefore, in this study, in order to identify the exact mechanism of quercetin-3-O-sophoroside performance and identify the amino acid residues involved in this process and the optimal energy of quercetin-3-O-sophoroside upon interaction with different SARS-CoV-2’s proteins including, E protein (ion channel), helicase ADP site, helicase NCB site, main protease, N protein NCB site, Nsp14 (ExoN), Nsp14 (N7-MTase), Nsp15 (endoribonuclease), Nsp16 (2′-O-MTase), papain-like protease, RdRp with RNA, and RdRp without RNA, molecular, docking and molecular dynamic studies were done. This information may provide some potential information about the control of SARS-CoV-2 and reported variants.

Material and methods

Global reactivity descriptors

The quercetin-3-O-sophoroside molecule geometry optimization was carried out using the PM3 semi-empirical method and a single point energy calculation was performed using Becke3-Parameter hybrid function which combined with the Lee–Yang– Parr correlation functional, abbreviated as B3LYP (Stephens et al., 1994, Lee et al., 1988) with the standard 6-31G(d,p) basis both implemented in the GAUSSIAN98W suite of programs (Frisch et al., 1998).

Molecular docking

In order to investigate the affinity of quercetin-3-O-sophoroside toward covid-19 virus's receptors molecular docking calculations were carried out using COVID-19 Docking Server (Kong et al., 2020). We used all proteins provided by this server, which uses the JSMol (http://jmol.sourceforge.net/) for molecular visualization, where the plots of complex configurations were extracted from this page.

Molecular dynamics study

In order to study the adsorption effects of quercetin-3-O-sophoroside on target proteins, E protein was selected as the receptor model. The molecular dynamics calculation was performed using HTMD software (Doerr et al., 2016). The GAFF2 method (Mayo et al., 1990) was employed for parameterization of the quercetin-3-O-sophoroside. Conditions were set at 1 atm pressure and 310 K. The software generated parameters in the AMBER-compatible format. The flipping of side chains and placement of missing hydrogen atoms at biological pH was done using Protein Prepare application (Doerr et al., 2016). All mentioned applications are available on PlayMolecule site (www.playmolecule.org). Also, visualization of the structures was done by using CHIMERA tool (www.cgl.ucsf.edu/chimera).

Results

Optimized geometry of quercetin-3-O-sophoroside

Fig. 1a depicts the optimized geometry of the quercetin-3-O-sophoroside molecule. As can be seen, this molecule consists of a quercetin part and a sugar moiety. Fig. 1b illustrates the molecular electrostatic potential as a descriptor for charge-controlled reactions. The negative electronic potential is shown in red, while the positive electrostatic potential is depicted in blue.
Fig. 1

Optimized geometry of the quercetin-3-O-sophoroside (a) Electrostatic potential surface of the molecule (b) The plot of HOMO (c) and LUMO (d).

Optimized geometry of the quercetin-3-O-sophoroside (a) Electrostatic potential surface of the molecule (b) The plot of HOMO (c) and LUMO (d). As shown in Fig. 1b, the most intense electrostatic potential regions are located on sugar moiety which can play an important role in interaction of the molecule with electrostatic active sites on the biomolecules. The calculated molecular orbitals (Fig. 1c and d) show the more favorable sites for redox reactions. The Highest Occupied Molecular Orbital (HOMO) plot shows electron donor sites and the Lowest Unoccupied Molecular Orbital (LUMO) plot shows electron acceptor sites. Although both orbitals mainly located on quercetin part, it has been proven that sugar moiety in this kind of compounds plays a vital role in biological activities. In order to study the structural-biological activity, at first the global reactivity descriptors of the quercetin-3-O-sophoroside molecule were calculated and the affinity of the molecule toward the SARS-CoV-2’s receptors was evaluated using molecular docking study. The global parameters of the quercetin-3-O-sophoroside molecule were calculated as following: The Ionization potential (I) and electron affinity (A) are given by: Which E HOMO and E LUMO represent the energies of the respective molecular orbitals. The chemical potential μ and the hardness η are expressed in terms of the ionization potential I and the electron affinity A (Koulgi et al., 2021): The calculated global reactivity parameters are gathered in Table 1 .
Table 1

Global molecular descriptors indicative of the reactive behavior of the quercetin-3-O-sophoroside molecule.

ParameterCalculated result
EHOMO (eV)−5.943
ELUMO (eV)−1.393
ΔELUMO-HOMO (eV)4.550
I=- EHOMO (eV)5.943
A=- ELUMO (eV)1.393
η=I-A2(eV)2.275
χ=I+A2(eV)3.668
Dipolemoment(Debye)1.0693
Global molecular descriptors indicative of the reactive behavior of the quercetin-3-O-sophoroside molecule. The relatively larger value of the quercetin-3-O-sophoroside molecular hardness with respect to similar value for other antioxidants which were calculated by similar method reveals a remarkable stability of the molecule.

Molecular docking results

In this study, molecular docking simulations between quercetin-3-O-sophoroside and different proteins such as E protein (ion channel) (Fig. 2 a), helicase ADP site (Fig. 2b), helicase NCB site (Fig. 2c), main protease (Fig. 2d), N protein NCB site (e), Nsp14 (ExoN) (Fig. 2f), Nsp14 (N7-MTase) (Fig. 2g), Nsp15 (endoribonuclease) (Fig. 2h), Nsp16 (2′-O-MTase) (Fig. 2h), papain-like protease (Fig. 2j), RdRp with RNA (Fig. 2k), and RdRp without RNA (Fig. 2l) were performed to obtain the respective binding energies, involved amino acid residues, and corresponding linkages between the ligand and the receptors. In this method, the binding energy or docking energy calculated is a set of intracellular energy and ligand internal energy.
Fig. 2

The best docked models’ visualization of the quercetin-3-O-sophoroside with different target proteins of SARS-CoV-2; the ligand is shown in purple. E protein (ion channel) (a), helicase ADP site (b), helicase NCB site (c), MmainpProtease (d), N protein NCB site (e), Nsp14 (ExoN) (f), Nsp14 (N7-MTase) (g), Nsp15 (endoribonuclease) (h), Nsp16 (2′-O-MTase) (i), papain-like protease (j),RdRp with RNA (k), and RdRp without RNA (l).

The best docked models’ visualization of the quercetin-3-O-sophoroside with different target proteins of SARS-CoV-2; the ligand is shown in purple. E protein (ion channel) (a), helicase ADP site (b), helicase NCB site (c), MmainpProtease (d), N protein NCB site (e), Nsp14 (ExoN) (f), Nsp14 (N7-MTase) (g), Nsp15 (endoribonuclease) (h), Nsp16 (2′-O-MTase) (i), papain-like protease (j),RdRp with RNA (k), and RdRp without RNA (l). The negative binding energy, the proper interactions, and the strong bond with the main amino acid residues in the active site are observed for most proteins upon interaction with quercetin-3-O-sophoroside (Table 2 ).
Table 2

Molecular docking results of the quercetin-3-O-sophoroside with SARS-CoV-2’s target proteins.

ReceptorsBinding energy (kcal/mol)
quercetin-3-O-sophoroside
1E protein (ion channel)−6.70 ± 0.58
2Helicase ADP site−7.10 ± 0.91
3Helicase NCB site−8.80 ± 0.45
4Main protease−8.70 ± 1.08
5N protein NCB site−8.70 ± 0.94
6Nsp14 (ExoN)−7.10 ± 0.67
7Nsp14 (N7-MTase)−9.10 ± 0.89
8Nsp15 (endoribonuclease)−7.10 ± 0.37
9Nsp16 (2′-O-MTase)−8.70 ± 0.92
10Papain-like protease−9.5 ± 0.67
11RdRp with RNA−9.70 ± 1.58
12RdRp without RNA−8.40 ± 1.12
Molecular docking results of the quercetin-3-O-sophoroside with SARS-CoV-2’s target proteins. Also, as can be seen in Table 2, the binding energies for quercetin-3-O-sophoroside are potentialy high in all cases which reveals the potency of the quercetin-3-O-sophoroside in inhibiting SARS-CoV-2’s enzymes and disruption in function of target proteins. From the binding energies presented in Table.2, we observed that the highest affinity of quercetin-3-O-sophoroside is related to the RdRp with RNA, the binding energy for this case is a considerable value of −9.70 ± 1.58 kcal/mol. On the other hand, E protein (ion channel), Helicase ADP site, Nsp14 (ExoN), and Nsp15 (endoribonuclease) with binding energies of −6.70 ± 0.58 kcal/mol, −7.10 ± 0.91 kcal/mol, −7.10 ± 0.67 kcal/mol, and −7.10 ± 0.37 kcal/mol, respectively showed the lowest binding energy among other proteins. Visualization of the docked pose was done using PyMOL (http://pymol.sourceforge.net/) tool. The ligand with surrounding active site residues within 4 Å is shown in Fig. 3 for E protein (ion channel) (Fig. 3a), helicase ADP site (Fig. 3b), helicase NCB site (Fig. 3c), main protease (Fig. 3d), N protein NCB site (Fig. 3e), Nsp14 (ExoN) (Fig. 3f), Nsp14 (N7-MTase) (Fig. 3g), Nsp15 (endoribonuclease) (Fig. 3h), Nsp16 (2′-O-MTase) (Fig. 3i), papain-like protease (Fig. 3j), RdRp with RNA (Fig. 3k), and RdRp without RNA (Fig. 3l). The nearest interacting residues are summarized in Table 3 .
Fig. 3

The interacting residues of the receptors with quercetin-3-O-sophoroside; E protein (ion channel) (a), helicase ADP site (b), helicase NCB site (c), main protease (d), N protein NCB site (e), Nsp14 (ExoN) (f), Nsp14 (N7-MTase) (g), Nsp15 (endoribonuclease) (h), Nsp16 (2′-O-MTase) (i), apain-like protease (j), RdRp with RNA (k), and RdRp without RNA (l).

Table 3

The nearest interacting residues and nucleotides.

LigandReceptorsResidue interacted
The minimum distance between ligand and receptors atoms (dm)dm < 4Ȧ
Quercetin-3-O-sophorosideE protein (ion channel)Phe-23, Phe-26, Leu-27, Thr-30, Val-47, Cys-43, Ile-46, Leu-51, Thr-35, Ala-32, Leu-31, Leu-28, Val-29
Helicase ADP siteArg-442, Thr-440, Thr-286, Gly-285, Gly-287, Ser-289, His-290, Lys-320, Lys-322, Tyr-324, Glu-261
Helicase NCB siteArg-409, Thr-410, Pro-408, His-230, Glu-143, Thr-228, Asn-179, Arg-178, Val-181, Arg-339, Ser-310, Asn-361, Cys-309, His-311
MaiproteaseGlu-166, Gln-189, Met-165, His-164, Cys-145, Gly-143, Asn-142, Asn-119, Asp-187
N protein NCB siteArg-41, Pro-42, Leu-45, Asn-48, Thr-49, Ala-50, Ser-51, Pro-151, Thr-91, Ala-90, Pro-117, Tyr-109
Nsp14 (ExoN)Phe-190, Glu-191, Ala-178, Val-91, Asp-90, Glu-92, Asn-252, Asp-273, Leu-235, His-268, Gln-145, Pro-141, Asn-104
Nsp14 (N7-MTase)Cys-309, Arg-310, Cys-310, Ile-338, Lys-339, Gln-313, Phe-401, Trp-385, Lys-336, Cys-387, Asn-334, Pro-335, Gly-333
Nsp15 (endoribonuclease)Trp-332, Lys-344, Pro-343, Tyr-342, Thr-340, Glu-339, Ser-293, His-249, Gly-247, Gly-246, His-234
Nsp16 (2′-O-MTase)Asp-75, Ser-74, Gly-73, Leu-100, Asp-99, Gly-71, Ala-72, Pro-134, Asp-130, Tyr-132, Met-131, Tyr-30, Asn-29, Glu-203, Lys-170, Lys-46
Papain-like proteaseMet-206, Tyr-207, Met-208, Gly-209, Tyr-268, Gln-269, Lys-157, Leu-162, Glu-161, Gly-160, Ile-222, Gln-221, Leu-199
RdRp with RNACys-622, Lys-621, Asp-623, Ser-682, Arg-555, Thr-556, Asp-452, G-8
RdRp without RNATyr-619, Asp-760, Ser-759, Arg-553, Arg-555, Thr-556, Val-557, Ser-682, Ser-681, Thr-680, Arg-624, Thr-687, Cys-622, Lys-621, Asp-623
The interacting residues of the receptors with quercetin-3-O-sophoroside; E protein (ion channel) (a), helicase ADP site (b), helicase NCB site (c), main protease (d), N protein NCB site (e), Nsp14 (ExoN) (f), Nsp14 (N7-MTase) (g), Nsp15 (endoribonuclease) (h), Nsp16 (2′-O-MTase) (i), apain-like protease (j), RdRp with RNA (k), and RdRp without RNA (l). The nearest interacting residues and nucleotides. Molecular docking studies have shown that the quercetin-3-O-sophoroside binds to RdRp with RNA protein by hydrogen bonding and electrostatic interactions. Indeed, the structure of quercetin-3-O-sophoroside forms hydrophilic interactions with the amino acid residues of Cys-622, Lys-621, Asp-623, Ser-682, Arg-555, Thr-556, Asp-452 as well as RNA G-8 nucleotide including. Indeed, due to the presence of sophoroside group in the ring structure of quercetin, the lipophilicity of this compound increases. The high lipophilicity of sophoroside group can affect the interaction of hydrophobic quercetin with the receptor as well as the possibility of virus penetration (host cell membrane permeability). In addition to the mentioned interactions, this drug is able to create π-π interactions, which is the connection between the phenyl ring and the phenyl amino acid ring Tyr-619 in the case of RdRp without RNA. The number of reversible bonds affects the physicochemical properties of the quercetin-3-O-sophoroside in oral administration as well as the spatial orientation of the compound at the site of protein binding. In other hand, it was revealed that in the case of RdRp without RNA, the binding energy was reduced to −8.40 kcal/mol, relative to RdRp with RNA. Therefore, it may be indicated that the dominance of hydrophilic residues and presence of G nucleotides provide a favorable environment for the interaction of RdRp with quercetin-3-O-sophoroside. RdRp is a nonstructural viral protein. This enzyme, which plays an important role in the virus cycle, is important in two ways: i), for its accessibility, ii) as an attractive target for antiviral compounds (Zhu et al., 2020, Aftab et al., 2020). The structure of the RdRp of SARS-CoV-2 is consisting of three subdomains and the functionally important catalytic sites of the RdRp are TRP 617, CYS 622, SER 759, ASP 760, ASP 761, CYS 813 (Koulgi et al., 2021). As can be seen in Table 1, some of ligand's neighboring sites are located in the catalytic region, which can terminate base pair chain elongation (Yin et al., 2020). A number of drugs approved by FDA which contain nucleotide analogues and non-nucleotide compounds have been tested in order to inhibit RdRp (Chien et al., 2020, Elfiky, 2020, Zhang and Zhou, 2020, Zhao and Bourne, 2020). In addition to these compounds, other ones containing phytochemicals and their metabolites have been also suggested to inhibit this enzyme (da Silva et al., 2020, Saakre et al., 2021). E protein (ion channel) has shown the weakest binding energy among the compounds studied, possibly due to the dominance of hydrophobic residues involved in the binding pocket with quercetin-3-O-sophoroside, namely Phe-23, Phe-26, Leu-27, Thr-30, Val-47, Cys-43, Ile-46, Leu-51, Thr-35, Ala-32, Leu-31, Leu-28, Val-29. These hydrophobic residues cause a reduction in hydrophilic interactions, which is not a potential target for the system. E protein as the smallest corona virus's structural protein, has an essential role in envelope formation, budding, assembly, and modulating viral pathogenesis (Ashour et al., 2020, Schoeman and Fielding, 2019). Ye and Hogue (2007), which its disruption can significantly cripple the virus. Therefore, it is important to explore some compounds that can interact with this protein. Several compounds have been proposed to inhibit corona virus's E protein (Singh Tomar and Arkin, 2020, Gupta et al., 2021). This protein has a large hydrophobic transmembrane domain, However, modeling this protein without considering the membrane may provide useful information on how it interacts with compounds that are introduced as drug candidates (Gupta et al., 2021).

Molecular dynamic study

The prediction of the conformational changes of the protein is the analysis of the structural status of each residue in the protein sequence in three possible forms: helix, sheet, and coil. Structural prediction is based on the fact that the protein structure has a regular arrangement of amino acids that are stabilized by different bonding patterns. The regularity of the structure is the main basis of predictive algorithms. The plot of root mean square deviation (RMSD) was shown in Fig. 4 . The RMSD values increased gradually in the first 9 ns, followed by a sharp increase for 4 ns, and after that, the system reached a point of equilibrium. The difference between the maximum and the minimum RMSD values over the rest of the time is about 1 nm. It might be attributed to a substantial conformational change of the protein.
Fig. 4

RMSD analysis for quercetin-3-O-sophoroside/E protein backbone (CA: blue) and side chain (yellow) during the molecular dynamic simulation.

RMSD analysis for quercetin-3-O-sophoroside/E protein backbone (CA: blue) and side chain (yellow) during the molecular dynamic simulation. Fig. 5 shows the plot of root mean square fluctuations (RMSF) of E protein backbone and side chains in the presence of quercetin-3-O-sophoroside, which is considered as the analysis of the thermal motions of each amino acid residue around its average position. The larger RMSF values indicate the substantial random motions of the amino acid residues. In fact as shown in Fig. 6 , more flexible residues (Evangelin et al., 2020, Deng et al., 2020, Wu et al., 2020, Zuo et al., 2020) are located in C-terminal tail of α -helix 1 (H1).
Fig. 5

RMSF analysis for quercetin-3-O-sophoroside/E protein backbone (CA: blue) and side chain (yellow) during the molecular dynamic simulation.

Fig. 6

Three-dimensional structure: of α-helix (H) and loop (L) in E protein.

RMSF analysis for quercetin-3-O-sophoroside/E protein backbone (CA: blue) and side chain (yellow) during the molecular dynamic simulation. Three-dimensional structure: of α-helix (H) and loop (L) in E protein. The second and third peaks in the graph are related to residues (40-45) and (55-59) located in loop 4 (L4) and N-terminal of chain A, respectively. In the chain B, residues (102–105) located in loop 3 (L3) have a moderate intensity in the RMSF graph while the most intense peak in the graph is related to residues (110–119) which are the constituent amino acids of α -helix 4 (H4). This instability can be induced by presence of the ligand in the vicinity of these residues. The other peaks in the RMSF graph are related to similar locations in adjacent chains. Fig. 7 also shows the structural changes of E protein (Fig. A) after interaction with quercetin-3-Osophoroside complex during 25 ns evolution (Fig. 7B).
Fig. 7

The structure of ligand/E protein complex in the initial (A) and after 25 ns evaluation (B) woth quercetin-3-O- sophoroside as a ligand.

The structure of ligand/E protein complex in the initial (A) and after 25 ns evaluation (B) woth quercetin-3-O- sophoroside as a ligand. Therefore, this study provides a clear reason for the more unstable or disintegration of the E protein structure in the presence of the quercetin-3-O-sophoroside. The change in protein shape and its denaturation can disrupt the functionality of the protein in the biological and non-biological environments. Based on this result and already published data (Babadaei et al., 2021, Babadaei et al., 2021, Sk et al., 2020, Basit et al., 2021), it can be indicated that some potential small molecules can be used in clinical settings to inhibit the main SARS-CoV-2’s proteins and enzymes. It should be also noted that cellular and molecular assays (Taheri et al., 2021) along with some classified information for determining protective practices (Barzinjy et al., 2021) should be considered to further obtain potential details about the control of this disease.

Conclusion

In this study, the interaction of quercetin-3-O-sophoroside with different SARS-CoV-2′ proteins including E protein (ion channel), helicase ADP site, helicase NCB site, main protease, N protein NCB site, Nsp14 (ExoN) Nsp14 (N7-MTase), Nsp15 (endoribonuclease), Nsp16 (2′-O-MTase), papain-like protease, RdRp with RNA, and RdRp without RNA and its effect on the structure of target proteins, main protease was studied by different molecular docking and molecular dynamic simulations to may provide useful information for control of SARS-CoV-2 and maybe its other variants, including Delta. The results of these studies suggested that the hydrophilic side chains of the proteins show the greatest tendency to interact with quercetin-3-O-sophoroside. In addition, it was shown that aromatic amino acids with a flat π-π structure can be adsorbed on the surface of quercetin-3-O-sophoroside. Regarding the changes in the secondary structure of protein, the helical structures, β-sheets and the loops have been changed in the structure of the protein. Although simulation in this study has yielded interpretable results, there are some limitations to such simulations, which are important barriers to a better understanding of how proteins are adsorbed and its dynamics on different surfaces. The first limitation is that these calculations begin with a specific protein orientation, while other possible orientations can lead to different protein behaviors and affect the final results. The second limitation is related to the simulation time, because longer simulation times can better represent system behavior, and ultimately the results are based on the parameters of the simulation field and other possible force fields can show other behaviors of the system. Therefore, considering the results of this study and based on the mentioned limitations, more studies are needed to prove the accuracy of the reported outcomes.

Funding

The authors gratefully acknowledge the China Postdoctoral Science Foundation research grant No. 2020M672291, Hepatobiliary Foundation of Henan Charity General Federation GDXZ2019006, and Qatar National Research Fund (a part of Qatar Foundation) grant No. NPRP10-0120-170211. The authors would also like to acknowledge GCC-2017-005 (Qatar University) and NPRP12S-0310-190276 (QNRF) grants. The statements made here are the sole responsibility of authors.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
  49 in total

1.  A comparison of the absorption and metabolism of the major quercetin in brassica, quercetin-3-O-sophoroside, to that of quercetin aglycone, in rats.

Authors:  Yanling Wang; Mark A Berhow; Molly Black; Elizabeth H Jeffery
Journal:  Food Chem       Date:  2019-11-09       Impact factor: 7.514

2.  Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient.

Authors:  Sean Wei Xiang Ong; Yian Kim Tan; Po Ying Chia; Tau Hong Lee; Oon Tek Ng; Michelle Su Yen Wong; Kalisvar Marimuthu
Journal:  JAMA       Date:  2020-04-28       Impact factor: 56.272

3.  SARS-CoV-2 E protein is a potential ion channel that can be inhibited by Gliclazide and Memantine.

Authors:  Prabhat Pratap Singh Tomar; Isaiah T Arkin
Journal:  Biochem Biophys Res Commun       Date:  2020-06-20       Impact factor: 3.575

4.  Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach.

Authors:  Sukanth Kumar Enmozhi; Kavitha Raja; Irudhayasamy Sebastine; Jerrine Joseph
Journal:  J Biomol Struct Dyn       Date:  2020-05-05

Review 5.  Coronavirus disease 2019 (COVID-19): a clinical update.

Authors:  Min Zhou; Xinxin Zhang; Jieming Qu
Journal:  Front Med       Date:  2020-04-02       Impact factor: 4.592

6.  Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2.

Authors:  Yadi Zhou; Yuan Hou; Jiayu Shen; Yin Huang; William Martin; Feixiong Cheng
Journal:  Cell Discov       Date:  2020-03-16       Impact factor: 10.849

7.  Letter to the Editor: Angiotensin-converting enzyme 2: an ally or a Trojan horse? Implications to SARS-CoV-2-related cardiovascular complications.

Authors:  Zaid Abassi; Suheir Assady; Emad E Khoury; Samuel N Heyman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-03-30       Impact factor: 4.733

Review 8.  The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China.

Authors:  Yongshi Yang; Fujun Peng; Runsheng Wang; Kai Guan; Taijiao Jiang; Guogang Xu; Jinlyu Sun; Christopher Chang
Journal:  J Autoimmun       Date:  2020-03-03       Impact factor: 7.094

9.  Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2.

Authors:  Seyed Fazel Nabavi; Solomon Habtemariam; Emilio Clementi; Ioana Berindan-Neagoe; Cosmin Andrei Cismaru; Mahsa Rasekhian; Maciej Banach; Morteza Izadi; Mahdi Bagheri; Mohammad Sadegh Bagheri; Seyed Mohammad Nabavi
Journal:  Arch Med Sci       Date:  2020-04-14       Impact factor: 3.318

10.  Flavonoid glycosides and their putative human metabolites as potential inhibitors of the SARS-CoV-2 main protease (Mpro) and RNA-dependent RNA polymerase (RdRp).

Authors:  Felipe Moura A da Silva; Katia Pacheco A da Silva; Luiz Paulo M de Oliveira; Emmanoel V Costa; Hector Hf Koolen; Maria Lúcia B Pinheiro; Antonia Queiroz L de Souza; Afonso Duarte L de Souza
Journal:  Mem Inst Oswaldo Cruz       Date:  2020-09-30       Impact factor: 2.743

View more
  1 in total

1.  Genome sequence analysis of SARS-COV-2 isolated from a COVID-19 patient in Erbil, Iraq.

Authors:  Bashdar Mahmud Hussen; Dana Khdr Sabir; Yasin Karim; Karzan Khawaraham Karim; Hazha Jamal Hidayat
Journal:  Appl Nanosci       Date:  2022-02-07       Impact factor: 3.869

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.